N-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-S-trityl-L-cysteine

Catalog No. :
ACZXMO150
CAS No. :
2244048-20-0
Molecular Formula :
C40H36N2O5S
Molecular Weight :
656.80

IUPAC Name:N-(3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-S-trityl-L-cysteine

N-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-S-trityl-L-cysteine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-S-trityl-L-cysteine
IUPAC NameN-(3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoyl)-S-trityl-L-cysteine
Molecular FormulaC40H36N2O5S
Molecular Weight656.80
SMILESO=C(O)[C@H](CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)NC(CCNC(OCC4C5=C(C6=C4C=CC=C6)C=CC=C5)=O)=O
InChI KeyXIKQAFILPGYFBZ-BHVANESWSA-N
Synonym(2R)-2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-3-[(triphenylmethyl)sulfanyl]propanoic acid;L-Cysteine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-β-alanyl-S-(triphenylmethyl)-;Acetylcysteine Impurity 76;N-(Fmoc-beta-alanyl)-S-trityl-L-cysteine
CAS No.2244048-20-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZXMO150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZXMO150 route product structure diagram
    ACZXMO1502244048-20-0
Inquiry

2. ACZXMO150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZXMO150 route product structure diagram
    ACZXMO1502244048-20-0
Inquiry

Comments (0)